The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationCardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Robbins pathologic basis of disease
Cotran, R. S., Kumar, V., & Collins, T. (1989) · Medical Entomology and Zoology · Cited by 1,944
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationComplications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
Nussmeier, N. A., Whelton, A. A., Brown, M. T., Langford, R. M., Hoeft, A., Parlow, J. L., Boyce, S. W., & Verburg, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050330 · Cited by 1,092
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Self-citationAnti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862
Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesisa
GIMBRONE, M. A., TOPPER, J. N., NAGEL, T., ANDERSON, K. R., & GARCIA‐CARDEÑA, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06318.x · Cited by 836
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Self-citationInflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Serhan, C. N., Hamberg, M., & Samuelsson, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5335 · Cited by 765
Self-citationThe Healing Hand: Man and Wound in the Ancient World
LOEFFEL, E. D. (1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03260230069032 · Cited by 731
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
Clària, J., & Serhan, C. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9475 · Cited by 700
Self-citationMolecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins
Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., & Serhan, C. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4345 · Cited by 699
Self-citationRobbins Pathologic Basis of Disease
Morrison, A. B. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.282.18.1776-a · Cited by 668
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., & Serhan, C. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409271102 · Cited by 590
Self-citationBiomechanical activation of vascular endothelium as a determinant of its functional phenotype
García-Cardeña, G., Comander, J., Anderson, K. R., Blackman, B. R., & Gimbrone, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071052598 · Cited by 523
Resolution of Inflammation: A New Paradigm for the Pathogenesis of Periodontal Diseases
Van Dyke, T. E., & Serhan, C. N. (2003) · Journal of Dental Research · doi:10.1177/154405910308200202 · Cited by 513
Self-citationThe Healing Hand: Man and Wound in the Ancient World
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-270_1 · Cited by 460
The development of COX2 inhibitors
Flower, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1034 · Cited by 459
Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 447
Self-citationIdentification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
Fiore, S., Maddox, J. F., Perez, H. D., & Serhan, C. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.253 · Cited by 436
Self-citationTakano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., & Serhan, C. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1693 · Cited by 431
Self-citationSerhan, C. N., Jain, A., Marleau, S., Clish, C., Kantarci, A., Behbehani, B., Colgan, S. P., Stahl, G. L., Merched, A., Petasis, N. A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6856 · Cited by 404
Self-citationMulti-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W., Drazen, J. M., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm748 · Cited by 352
Self-citationDefective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Karp, C. L., Flick, L. M., Park, K. W., Softic, S., Greer, T. M., Keledjian, R., Yang, R., Uddin, J., Guggino, W. B., Atabani, S. F., et al. (2004) · Nature Immunology · doi:10.1038/ni1056 · Cited by 344
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationSerhan, C. N., & Sheppard, K. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114503 · Cited by 313
Self-citationSerhan, C. N., Gotlinger, K., Hong, S., & Arita, M. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.03.005 · Cited by 310
Self-citationGronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., & Laniado Schwartzman, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 310
The Productive Conformation of Arachidonic Acid Bound to Prostaglandin Synthase
Malkowski, M. G., Ginell, S. L., Smith, W. L., & Garavito, R. M. (2000) · Science · doi:10.1126/science.289.5486.1933 · Cited by 308
Libby, P. (2002) · Scientific American · doi:10.1038/scientificamerican0502-46 · Cited by 304
Cells, tissues, and disease : principles of general pathology
Majno, G., & Joris, I. (1996) · Cited by 303
Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro
Marcus, A. J., Broekman, M. J., Safier, L. B., Ullman, H. L., Islam, N., Serhan, C. N., Rutherford, L. E., Korchak, H. M., & Weissmann, G. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91575-3 · Cited by 299
Self-citationCanny, G., Levy, O., Furuta, G. T., Narravula-Alipati, S., Sisson, R. B., Serhan, C. N., & Colgan, S. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052533799 · Cited by 295
Self-citationMaddox, J. F., & Serhan, C. N. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.137 · Cited by 294
Self-citationMitchell, S., Thomas, G., Harvey, K., Cottell, D., Reville, K., Berlasconi, G., Petasis, N. A., Erwig, L., Rees, A. J., Savill, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032417.73640.72 · Cited by 287
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
Brink, C., Dahlén, S.-E., Drazen, J., Evans, J. F., Hay, D. W. P., Nicosia, S., Serhan, C. N., Shimizu, T., & Yokomizo, T. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.8 · Cited by 286
Self-citationMamdani, M., Rochon, P., Juurlink, D. N., Anderson, G. M., Kopp, A., Naglie, G., Austin, P. C., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.481 · Cited by 281
Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury
Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L. E., & Levy, B. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.5033 · Cited by 275
Lipoxin biosynthesis and its impact in inflammatory and vascular events
Serhan, C. N. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90185-6 · Cited by 273
Self-citationMaddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6972 · Cited by 266
Self-citationChiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S., & Serhan, C. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405445101 · Cited by 266
Self-citationLipoxin A4: A New Class of Ligand for the Ah Receptor
Schaldach, C. M., Riby, J., & Bjeldanes, L. F. (1999) · Biochemistry · doi:10.1021/bi982861e · Cited by 264
Chiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1197 · Cited by 260
Self-citationAliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N., & Sher, A. (2002) · Nature Immunology · doi:10.1038/ni745 · Cited by 258
Self-citationAspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., & Marnett, L. J. (1998) · Science · doi:10.1126/science.280.5367.1268 · Cited by 258
Gewirtz, A. T., Collier-Hyams, L. S., Young, A. N., Kucharzik, T., Guilford, W. J., Parkinson, J. F., Williams, I. R., Neish, A. S., & Madara, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5260 · Cited by 256
Trihydroxytetraenes: A novel series of compounds formed from arachidonic acid in human leukocytes
Serhan, C. N., Hamberg, M., & Samuelsson, B. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91486-4 · Cited by 255
Self-citationJózsef, L., Zouki, C., Petasis, N. A., Serhan, C. N., & Filep, J. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202296999 · Cited by 254
Self-citationSerhan, C. N. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00001-4 · Cited by 241
Self-citationInduction of 15-lipoxygenase by interleukin-13 in human blood monocytes.
Nassar, G. M., Morrow, J. D., Roberts, L. J., Lakkis, F. G., & Badr, K. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47031-7 · Cited by 233
Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
Shen, J., Herderick, E., Cornhill, J. F., Zsigmond, E., Kim, H. S., Kühn, H., Guevara, N. V., & Chan, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119029 · Cited by 233
Takano, T., Clish, C. B., Gronert, K., Petasis, N., & Serhan, C. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1578 · Cited by 230
Self-citationCells, tissues and disease principles of general pathology
Mulligan, P. T. (1997) · Biochemical Education · doi:10.1016/s0307-4412(97)85220-x · Cited by 227
Hansson, A., Serhan, C. N., Haeggström, J., Ingelman-Sundberg, M., Samuelsson, B., & Morris, J. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90380-3 · Cited by 225
Self-citationPapayianni, A., Serhan, C. N., & Brady, H. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.6.2264 · Cited by 224
Self-citationChiang, N., Gronert, K., Clish, C. B., O’Brien, J. A., Freeman, M. W., & Serhan, C. N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7016 · Cited by 218
Self-citationSodin-Semrl, S., Taddeo, B., Tseng, D., Varga, J., & Fiore, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2660 · Cited by 215
Lee, T. H., Horton, C. E., Kyan-Aung, U., Haskard, D., Crea, A. E. G., & Spur, B. W. (1989) · Clinical Science · doi:10.1042/cs0770195 · Cited by 215
Clish, C. B., O’Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., & Serhan, C. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8247 · Cited by 212
Self-citationLipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers.
Colgan, S. P., Serhan, C. N., Parkos, C. A., Delp-Archer, C., & Madara, J. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116601 · Cited by 211
Self-citationPouliot, M., Clish, C. B., Petasis, N. A., Van Dyke, T. E., & Serhan, C. N. (2000) · Biochemistry · doi:10.1021/bi992551b · Cited by 207
Self-citationGronert, K., Gewirtz, A., Madara, J. L., & Serhan, C. N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1285 · Cited by 207
Self-citationHachicha, M., Pouliot, M., Petasis, N. A., & Serhan, C. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1923 · Cited by 199
Self-citationLevy, B. D., Romano, M., Chapman, H. A., Reilly, J. J., Drazen, J., & Serhan, C. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116738 · Cited by 196
Self-citationProinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?
Netea, M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00079-6 · Cited by 195
Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy.
Brezinski, D. A., Nesto, R. W., & Serhan, C. N. (1992) · Circulation · doi:10.1161/01.cir.86.1.56 · Cited by 193
Self-citationClària, J., Lee, M. H., & Serhan, C. N. (1996) · Molecular Medicine · doi:10.1007/bf03401642 · Cited by 192
Self-citationThe opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase
Vance, R. E., Hong, S., Gronert, K., Serhan, C. N., & Mekalanos, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307308101 · Cited by 192
Self-citationMaderna, P., Yona, S., Perretti, M., & Godson, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3727 · Cited by 190
Oxidoreductases in Lipoxin A4 Metabolic Inactivation
Clish, C. B., Levy, B. D., Chiang, N., Tai, H.-H., & Serhan, C. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002863200 · Cited by 184
Self-citationCronstein, B. N., Montesinos, M. C., & Weissmann, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6377 · Cited by 182
Fiore, S., & Serhan, C. N. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.5.1451 · Cited by 177
Self-citationDevchand, P. R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R., Gronert, K., & Serhan, C. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0770com · Cited by 176
Self-citationAriel, A., Chiang, N., Arita, M., Petasis, N. A., & Serhan, C. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6266 · Cited by 174
Self-citationBrezinski, M. E., & Serhan, C. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6248 · Cited by 171
Self-citationLehr, H. A., Frei, B., & Arfors, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7688 · Cited by 167
Gronert, K., Martinsson-Niskanen, T., Ravasi, S., Chiang, N., & Serhan, C. N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63937-5 · Cited by 166
Self-citationGewirtz, A. T., McCormick, B., Neish, A. S., Petasis, N. A., Gronert, K., Serhan, C. N., & Madara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1339 · Cited by 158
Self-citationThe Effects of Lipoxin A 4 on Airway Responses in Asthmatic Subjects
Christie, P. E., Spur, B. W., & Lee, T. H. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1281 · Cited by 158
Fierro, I. M., Kutok, J. L., & Serhan, C. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.385 · Cited by 158
Self-citationBadr, K. F., DeBoer, D. K., Schwartzberg, M., & Serhan, C. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3438 · Cited by 153
Self-citationLipoxins: endogenous regulators of inflammation
McMahon, B. A., & Godson, C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00224.2003 · Cited by 151
Munger, K. A., Montero, A., Fukunaga, M., Uda, S., Yura, T., Imai, E., Kaneda, Y., Valdivielso, J. M., & Badr, K. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13375 · Cited by 148
Fiorucci, S., Wallace, J. L., Mencarelli, A., Distrutti, E., Rizzo, G., Farneti, S., Morelli, A., Tseng, J., Suramanyam, B., Guilford, W. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404722101 · Cited by 147
TH2 and ‘TH2-like’ cells in allergy and asthma: pharmacological perspectives
Anderson, G. P., & Coyle, A. J. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90027-2 · Cited by 146
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways
Serhan, C. N., & Oliw, E. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13375 · Cited by 145
Self-citationLeonard, M. O., Hannan, K., Burne, M. J., Lappin, D. W. P., Doran, P., Coleman, P., Stenson, C., Taylor, C. T., Daniels, F., Godson, C., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000015795.74094.91 · Cited by 145
COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs: Do They Really Offer Any Advantages?
Jackson, L., & Hawkey, C. J. (2000) · Drugs · doi:10.2165/00003495-200059060-00001 · Cited by 145
Heasman, S. J., Giles, K., Ward, C., Rossi, A., Haslett, C., & Dransfield, I. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780029 · Cited by 142
Lipoxins: revelations on resolution
McMahon, B. A., Mitchell, S., Brady, H. R., & Godson, C. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01771-5 · Cited by 142
Endothelial Dysfunction, Hemodynamic Forces, and Atherosclerosis
Gimbrone, M. A. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615903 · Cited by 142
Lipoxins Are Potential Endogenous Antiinflammatory Mediators in Asthma
Bonnans, C., Vachier, I., Chavis, C., Godard, P., Bousquet, J. J., & Chanez, P. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200201-053oc · Cited by 140
Bannenberg, G. L., Moussignac, R., Gronert, K., Devchand, P. R., Schmidt, B. A. R., Guilford, W. J., Bauman, J. G., Subramanyam, B., Perez, H. D., Parkinson, J. F., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705912 · Cited by 140
Self-citationBandeira‐Melo, C., Serra, M. F., Diaz, B. L., Cordeiro, R. S. B., Silva, P., Lenzi, H. L., Bakhle, Y. S., Serhan, C. N., & Martins, M. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1029 · Cited by 135
Self-citationSamuelsson, B. O. (1983) · Bioscience Reports · doi:10.1007/bf01133779 · Cited by 129
Fiorucci, S., Santucci, L., Wallace, J. L., Sardina, M., Romano, M., Soldato, P. D., & Morelli, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933204100 · Cited by 123
Fiore, S., & Serhan, C. N. (1995) · Biochemistry · doi:10.1021/bi00051a016 · Cited by 118
Self-citationLehr, H. A., Olofsson, A. M., Carew, T. E., Vajkoczy, P., von Andrian, U. H., Hübner, C., Berndt, M. C., Steinberg, D., Messmer, K., & Ke, A. (1994) · PubMed · Cited by 118
Lipoxin A4 Antagonizes the Mitogenic Effects of Leukotriene D4 in Human Renal Mesangial Cells
McMahon, B. A., Stenson, C., McPhillips, F., Fanning, A., Brady, H. R., & Godson, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001015200 · Cited by 117
Bandeira‐Melo, C., Bozza, P. T., Diaz, B. L., Cordeiro, R. S. B., Jose, P. J., Martins, M. A., & Serhan, C. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2267 · Cited by 116
Self-citationL'Heureux, G., Bourgoin, S. G., Jean, N., et al. (1995) · Blood · doi:10.1182/blood.v85.2.522.522 · Cited by 113
Lipoxin, leukotriene, and PDGF receptors cross‐talk to regulate mesangial cell proliferation
Mahon, B. M., Mitchell, D., Shattock, R., Martin, F., Brady, H. R., & Godson, C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0416fje · Cited by 111
Serhan, C. N., Fiore, S., Brezinski, D. A., & Lynch, S. (1993) · Biochemistry · doi:10.1021/bi00076a002 · Cited by 109
Self-citationFilep, J. G., Zouki, C., Petasis, N. A., Hachicha, M., & Serhan, C. N. (1999) · Blood · doi:10.1182/blood.v94.12.4132 · Cited by 107
Self-citationSerhan, C. N., Fierro, I. M., Chiang, N., & Pouliot, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3650 · Cited by 104
Self-citationScalia, R. G., Gefen, J., Petasis, N. A., Serhan, C. N., & Lefer, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9967 · Cited by 104
Self-citationChiang, N., Takano, T., Clish, C. B., Petasis, N. A., Tai, H., & Serhan, C. N. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37857-7 · Cited by 102
Self-citationEdenius, C., Haeggström, J. Z., & Lindgren, J. Å. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80320-6 · Cited by 102
Levy, B. D., Fokin, V. V., Clark, J. M., Wakelam, M. J. O., Petasis, N. A., & Serhan, C. N. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.903 · Cited by 101
Self-citationAn Aspirin-Triggered Lipoxin A4 Stable Analog Displays a Unique Topical Anti-Inflammatory Profile
Schottelius, A. J. G., Giesen, C., Asadullah, K., Fierro, I. M., Colgan, S. P., Bauman, J. G., Guilford, W., Perez, H. D., & Parkinson, J. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.7063 · Cited by 99
Exogenous Pathogen and Plant 15-Lipoxygenase Initiate Endogenous Lipoxin A4 Biosynthesis
Bannenberg, G. L., Aliberti, J., Hong, S., Sher, A., & Serhan, C. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031325 · Cited by 98
Self-citationLipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease
Kieran, N. E., MADERNA, P., & Godson, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00487.x · Cited by 97
Pouliot, M., McDonald, P. P., Borgeat, P., & McColl, S. R. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1225 · Cited by 93
Maddox, J. F., Colgan, S. P., Clish, C. B., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.6.487 · Cited by 91
Self-citationAdventures and excursions in bioassay: the stepping stones to prostacyclin
Vane, J. R. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb10020.x · Cited by 90
Rowlinson, S. W., Crews, B. C., Goodwin, D. C., Schneider, C. G., Gierse, J. K., & Marnett, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6586 · Cited by 87
Pettitt, T. R., Rowley, A. F., Barrow, S. E., Mallet, A. I., & Secombes, C. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31505-9 · Cited by 84
Lipoxin generation by permeabilized human platelets
Romano, M., & Serhan, C. N. (1992) · Biochemistry · doi:10.1021/bi00150a021 · Cited by 81
Self-citationSerhan, C. N. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90264-6 · Cited by 81
Self-citationChavis, C., Vachier, I., Chanez, P., Bousquet, J., & Godard, P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1633 · Cited by 81
Guilford, W. J., Bauman, J. G., Skuballa, W., Bauer, S. M., Wei, G. P., Davey, D., Schaefer, C. J., Mallari, C. R., Terkelsen, J., Tseng, J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030569l · Cited by 80
Lee, T. H., Lympany, P., Crea, A., et al. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81354-3 · Cited by 79
L ipoxins in C hronic I nflammation
Kantarcı, A., & Dyke, T. E. V. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400102 · Cited by 77
Lipoxins Inhibit Akt/PKB Activation and Cell Cycle Progression in Human Mesangial Cells
Mitchell, D., Rodgers, K., Hanly, J. A., McMahon, B. A., Brady, H. R., Martin, F., & Godson, C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63181-1 · Cited by 74
Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures
Nobelstiftelsen (1982) · Almqvist & Wiksell International eBooks · Cited by 70
Gewirtz, A. T., Fokin, V. V., Petasis, N. A., Serhan, C. N., & Madara, J. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.4.c988 · Cited by 66
Self-citationA magic bullet for mucosal protection…and aspirin is the trigger!
Wallace, J. L., & Fiorucci, S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00166-4 · Cited by 64
Qiu, F.-H., Devchand, P. R., Wada, K., & Serhan, C. N. (2001) · The FASEB Journal · doi:10.1096/fj.01-0576fje · Cited by 63
Self-citationFirst total synthesis of 7(S),16(R),17(S)-Resolvin D2, a potent anti-inflammatory lipid mediator
Rodríguez, A. R., & Spur, B. W. (2004) · Tetrahedron Letters · doi:10.1016/j.tetlet.2004.09.129 · Cited by 63
Ohira, T., Bannenberg, G. L., Arita, M., Takahashi, M., Ge, Q., Dyke, T. E. V., Stahl, G. L., Serhan, C. N., & Badwey, J. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2091 · Cited by 61
Self-citationPlanagumà, A., Titos, E., López‐Parra, M., Gaya, J., Pueyo, G., Arroyo, V., & Clària, J. (2002) · The FASEB Journal · doi:10.1096/fj.02-0224fje · Cited by 60
Aspirin-like molecules that covalently inactivate cyclooxygenase-2
Kalgutkar, A. S. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., Marnett, L. J., & Kresge, A. J. (1999) · Cited by 58
Fiorucci, S., Distrutti, E., Mencarelli, A., Morelli, A., Laufer, S., Cirino, G., & Wallace, J. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705356 · Cited by 56
Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia
Levy, O., Canny, G., Serhan, C. N., & Colgan, S. P. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310795 · Cited by 54
Self-citationRing, W. L., Riddick, C. A., Baker, J. R., Munafo, D. A., & Bigby, T. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118545 · Cited by 54
Cyclooxygenase‐2 inhibitors: promise or peril?
Mengle-Gaw, L. J., & Schwartz, B. D. (2002) · Mediators of Inflammation · doi:10.1080/09629350290000041 · Cited by 52
Lipoxin Biosynthesis by Trout Macrophages Involves the Formation of Epoxide Intermediates
Rowley, A. F., Lloyd-Evans, P., Barrow, S. E., & Serhan, C. N. (1994) · Biochemistry · doi:10.1021/bi00170a002 · Cited by 51
Self-citationMancini, J. A., Vickers, P. J., O’Neill, G. P., Boily, C., Falgueyret, J., & Riendeau, D. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.52 · Cited by 47
Corey, E. J., & Mehrotra, M. M. (1986) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)85161-8 · Cited by 46
Clish, C. B., Sun, Y., & Serhan, C. N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5841 · Cited by 46
Self-citationAdventures and Excursions in Bioassay: The Stepping Stones to Prostacylin
Vane, J. R. (2004) · Bioscience Reports · doi:10.1007/s10540-005-2734-7 · Cited by 46
Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium
Kucharzik, T. F., Gewirtz, A. T., Merlin, D., Madara, J., & Williams, I. R. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00507.2001 · Cited by 44
Differential inside-out activation of β2-integrins by leukotriene B4 and fMLP in human neutrophils
Brodin, V. P., Wigren, J., Winberg, M. E., Rasmusson, B. J., Li, J., & Särndahl, E. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.015 · Cited by 40
Fiore, S., & Serhan, C. N. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90017-x · Cited by 39
Self-citationLipoxins in asthma: potential therapeutic mediators on bronchial inflammation?
Bonnans, C., Chanez, P., & Chavis, C. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00617.x · Cited by 39
Leukotrienes, Sphingolipids, and Leukocyte Trafficking
Yopp, A. C., Randolph, G. J., & Bromberg, J. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.5 · Cited by 37
Devchand, P. R., Schmidt, B. A. R., Primo, V., Zhang, Q., Arnaout, M. A., Serhan, C. N., & Nikolic, B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2565com · Cited by 34
Self-citationEndogenous Chemical Mediators in Anti-Inflammation and Pro-Resolution
Serhan, C. N. (2002) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1568014023355881 · Cited by 31
Self-citationRomano, M., Luciotti, G., Gangemi, S., Marinucci, F., Prontera, C., D’Urbano, E., & Davı̀, G. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000028823.53486.4a · Cited by 30
Gronert, K., Colgan, S. P., & Serhan, C. N. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37404-x · Cited by 27
Self-citationTargeting inflammatory diseases via apoptotic mechanisms
Murphy, F. J., Hayes, I., & Cotter, T. G. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00072-9 · Cited by 25
Serhan, C. N. (2001) · PubMed · Cited by 23
Self-citationFerrante, J. V., & Ferrante, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3169 · Cited by 21
Structure-based drug design: applications in immunopharmacology and immunosuppression
Navia, M. A., & Peattie, D. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90049-q · Cited by 21
Lipoxins: novel anti-inflammatory therapeutics?
Godson, C., & Brady, H. R. (2000) · PubMed · Cited by 18
First Total Synthesis of 7(S),16(R),17(S)‐Resolvin D2, a Potent Antiinflammatory Lipid Mediator.
Rodrı́guez, A. R., & Spur, B. W. (2005) · ChemInform · doi:10.1002/chin.200508224 · Cited by 8
Cited by
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Self-citationInflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationThe Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Self-citation
Metadata
- Authors
- Serhan, C. N.
- Venue
- Prostaglandins, Leukotrienes and Essential Fatty Acids
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 73
- Issue
- 3-4
- Pages
- 141-162
- ISSN
- 0952-3278 (ISSN-L)
- OpenAlex
- W2113203684
- Cited by
- 454
- References
- 172
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.